{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:20:07Z","timestamp":1784820007741,"version":"3.55.0"},"reference-count":24,"publisher":"American Diabetes Association","issue":"12","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":2845,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,12,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To estimate the prevalence of and risk factors for diabetic peripheral neuropathy (DPN) in a pilot study among youth participating in the SEARCH for Diabetes in Youth study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>DPN was assessed using the Michigan Neuropathy Screening Instrument (MNSI) (examination for foot abnormalities, distal vibration perception, and ankle reflexes). An MNSI exam (MNSIE) score &amp;gt;2 is diagnostic for DPN.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The MNSIE was completed in 399 subjects, including 329 youth with type 1 diabetes (mean age 15.7 \u00b1 4.3 years, duration 6.2 \u00b1 0.9 years) and 70 with type 2 diabetes (mean age 21.6 \u00b1 4.1 years, duration 7.6 \u00b1 1.8 years). Glycated hemoglobin (A1C) was similar in both groups (8.8 \u00b1 1.8% for type 1 vs. 8.5 \u00b1 2.9% for type 2). The prevalence of DPN was significantly higher in youth with type 2 compared with those with type 1 diabetes (25.7 vs. 8.2%; P &amp;lt; 0.0001). In unadjusted analyses, diabetes type, older age, longer duration of diabetes, increased waist circumference, elevated blood pressure, lower HDL cholesterol, and presence of microalbuminuria (urinary albumin-to-creatinine ratio &amp;gt;30 mg\/g) were associated with DPN. The association between diabetes type and DPN remained significant after adjustment for age and sex (odds ratio 2.29 [95% CI 1.05\u20135.02], P = 0.03).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>DPN prevalence among youth with type 2 diabetes approached rates reported in adult populations with diabetes. Our findings suggest not only that youth with diabetes are at risk for DPN but also that many already show measurable signs of DPN.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc13-1213","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T03:07:22Z","timestamp":1382411242000},"page":"3903-3908","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":95,"title":["Peripheral Neuropathy in Adolescents and Young Adults With Type 1 and Type 2 Diabetes From the SEARCH for Diabetes in Youth Follow-up Cohort"],"prefix":"10.2337","volume":"36","author":[{"given":"Mamta","family":"Jaiswal","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Lauer","sequence":"additional","affiliation":[{"name":"Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine L.","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny A.","family":"Bell","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Divers","sequence":"additional","affiliation":[{"name":"Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Dabelea","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Colorado School of Public Health, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Pettitt","sequence":"additional","affiliation":[{"name":"Sansum Diabetes Research Institute, Santa Barbara, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Saydah","sequence":"additional","affiliation":[{"name":"Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Pihoker","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra A.","family":"Standiford","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Children's Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz L.","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Kuakini Medical Center, University of Hawaii School of Medicine, Honolulu, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodica","family":"Pop-Busui","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva L.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the SEARCH for Diabetes in Youth Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2013,11,13]]},"reference":[{"key":"2022031222344988500_B1","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1007\/s00125-012-2571-8","article-title":"Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase","volume":"55","author":"Patterson","year":"2012","journal-title":"Diabetologia"},{"key":"2022031222344988500_B2","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.2337\/diacare.27.7.1798","article-title":"Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop","volume":"27","author":"Alberti","year":"2004","journal-title":"Diabetes Care"},{"key":"2022031222344988500_B3","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.2337\/dc12-0669","article-title":"Projections of type 1 and type 2 diabetes burden in the U.S. population aged &lt;20 years through 2050: dynamic modeling of incidence, mortality, and population growth","volume":"35","author":"Imperatore","year":"2012","journal-title":"Diabetes Care"},{"key":"2022031222344988500_B4","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"key":"2022031222344988500_B5","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s001250050586","article-title":"Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study","volume":"39","author":"Tesfaye","year":"1996","journal-title":"Diabetologia"},{"key":"2022031222344988500_B6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"key":"2022031222344988500_B7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1758-5996-4-21","article-title":"The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country","volume":"4","author":"Katulanda","year":"2012","journal-title":"Diabetol Metab Syndr"},{"key":"2022031222344988500_B8","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc09-1941","article-title":"Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study","volume":"33","author":"Albers","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031222344988500_B9"},{"key":"2022031222344988500_B10","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc12-s011","article-title":"Standards of medical care in diabetes\u20142012","volume":"35","author":"American Diabetes Association","year":"2012","journal-title":"Diabetes Care"},{"key":"2022031222344988500_B11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2337\/diacare.17.11.1281","article-title":"A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy","volume":"17","author":"Feldman","year":"1994","journal-title":"Diabetes Care"},{"key":"2022031222344988500_B12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.clineuro.2005.08.003","article-title":"Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy","volume":"108","author":"Moghtaderi","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"2022031222344988500_B13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1464-5491.2012.03644.x","article-title":"Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications","volume":"29","author":"Herman","year":"2012","journal-title":"Diabet Med"},{"key":"2022031222344988500_B14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cct.2004.08.002","article-title":"SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth","volume":"25","author":"SEARCH Study Group","year":"2004","journal-title":"Control Clin Trials"},{"key":"2022031222344988500_B15","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2337\/dc05-2470","article-title":"Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes","volume":"29","author":"Eppens","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031222344988500_B16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1056-8727(00)00078-7","article-title":"A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy","volume":"14","author":"Olsen","year":"2000","journal-title":"J Diabetes Complications"},{"key":"2022031222344988500_B17","first-page":"1087","article-title":"High prevalence of diabetic polyneuropathy in a group of Brazilian children with type 1 diabetes mellitus","volume":"18","author":"Nery Ferreira","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2022031222344988500_B18"},{"key":"2022031222344988500_B19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/dc07-1796","article-title":"Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA\/KORA Augsburg Surveys S2 and S3","volume":"31","author":"Ziegler","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031222344988500_B20","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2337\/diab.38.11.1456","article-title":"Epidemiological correlates of diabetic neuropathy","volume":"38","author":"Maser","year":"1989","journal-title":"Diabetes"},{"key":"2022031222344988500_B21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2337\/diab.46.4.665","article-title":"Hypertension as a risk factor for diabetic neuropathy: a prospective study","volume":"46","author":"Forrest","year":"1997","journal-title":"Diabetes"},{"key":"2022031222344988500_B22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1399-5448.2011.00762.x","article-title":"Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes from 1990 to 2006","volume":"12","author":"Cho","year":"2011","journal-title":"Pediatr Diabetes"},{"key":"2022031222344988500_B23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1464-5491.1999.00024.x","article-title":"Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus","volume":"16","author":"Olsen","year":"1999","journal-title":"Diabet Med"},{"key":"2022031222344988500_B24","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/dc12-s004","article-title":"Executive summary: Standards of medical care in diabetes\u20142012","volume":"35","author":"American Diabetes Association","year":"2012","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/36\/12\/3903\/614328\/3903.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/36\/12\/3903\/614328\/3903.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T00:49:11Z","timestamp":1647132551000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/36\/12\/3903\/33004\/Peripheral-Neuropathy-in-Adolescents-and-Young"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,13]]},"references-count":24,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,11,13]]},"published-print":{"date-parts":[[2013,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc13-1213","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,13]]}}}